Related Experiment Video
Updated: Aug 5, 2026

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
Published on: September 18, 2014
The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential
Yi Wang1, Juan Angulo-Lozano1,2, Yueqi Wang1,3
1Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.
Abstract:
The cGAS/STING pathway is a central innate immune DNA-sensing system that links aberrant DNA species to innate immune and stress-response transcriptional programs and has emerged as a key regulator of tumor-immune interactions. In cancer, pathway outputs are shaped by interconnected downstream signaling modules, including type I IFN, NF-κB, autophagy, and stress-metabolic checkpoints, as well as by stringent spatial and biochemical regulation of both cGAS and STING. When activation is acute and appropriately compartmentalized, cGAS/STING signaling promotes antitumor immunity across multiple cellular compartments in the tumor microenvironment, supporting DC cross-priming and cytotoxic lymphocyte responses. In contrast, chronic or dysregulated activation rewires downstream signaling toward stress-adaptive and inflammatory programs that promote tumor progression, metastasis, and immune dysfunction, including deleterious effects in lymphocytes and the induction of suppressive myeloid and B cell populations. Here, we examine how context determines the consequences of cGAS/STING activation in cancer, review emerging therapeutic strategies that modulate this pathway, and discuss how its antitumor potential can be maximized while minimizing systemic toxicity and immune dysregulation.
Insights
The cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway plays a dual role in cancer immunity. Acute activation promotes anti-tumor responses, while chronic activation can drive tumor progression and immune suppression.
Area of Science:
- Innate immunity
- Cancer immunology
- DNA sensing
Background:
- The cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway is a crucial innate immune sensor for aberrant DNA.
- This pathway regulates transcriptional programs linking DNA sensing to immune and stress responses.
- It is a key regulator of tumor-immune interactions.
Purpose of the Study:
- To examine how context dictates the consequences of cGAS/STING pathway activation in cancer.
- To review emerging therapeutic strategies targeting the cGAS/STING pathway.
- To discuss maximizing the pathway's antitumor potential while minimizing toxicity.
Main Methods:
- Review of existing literature on cGAS/STING pathway in cancer.
- Analysis of downstream signaling modules (e.g., type I IFN, NF-κB, autophagy).
- Examination of spatial and biochemical regulation of cGAS and STING.
Main Results:
- Acute, compartmentalized cGAS/STING activation promotes anti-tumor immunity (DC cross-priming, cytotoxic lymphocytes).
- Chronic or dysregulated activation promotes tumor progression, metastasis, and immune dysfunction.
- Dysregulation leads to suppressive myeloid and B cell populations and lymphocyte dysfunction.
Conclusions:
- Context-dependent activation of cGAS/STING has opposing effects in cancer.
- Therapeutic strategies must carefully modulate the pathway to harness anti-tumor effects and avoid immune suppression.
- Balancing pathway activation is key to effective cancer immunotherapy.
More Related Videos
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway
Signal Transduction: Overview
Typically, signal transduction involves three...